🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  2. Spinraza 12 mg solution for injection

    Biogen

    Spinal Muscular Atrophy

    approved small molecule active

    1 trial

  3. Standard BP control

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  4. Standard clinical care first, followed by standard clinical care and varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved small molecule completed

    1 trial

  5. Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum

    United Therapeutics Europe Ltd

    Frostbite

    approved small molecule active

    1 trial

  6. Stereotactic Radiation Therapy

    GT Biopharma

    Glioblastoma

    approved other terminated

    1 trial

  7. Stimulant or sedative

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  8. Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  9. Subcutaneous Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    1 trial

  10. Subcutaneous depot medroxyprogesterone acetate

    Protara Therapeutics

    Contraception

    approved small molecule completed

    1 trial

  11. Sublingual film containing Igalmi

    BioXcel Therapeutics

    Bipolar Disorder

    approved small molecule completed

    1 trial

  12. Sublocade

    Indivior Pty Ltd

    Opioid Use Disorder, Severe

    approved small molecule completed

    1 trial

  13. Suboxone Sublingual Film

    Indivior Pty Ltd

    Opioid Dependence

    approved small molecule completed

    1 trial

  14. Suboxone, Buprenorphine Hydrochloride + Naloxone, SCH 484

    Indivior Pty Ltd

    Opiate Dependence

    approved small molecule completed

    1 trial

  15. Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  16. Sufentanil

    The First People's Hospital of Lianyungang

    Arteriovenous Malformation

    approved small molecule active

    1 trial

  17. Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial

  18. Sulfato de Magnesio Altan 150 mg/ml solución inyectable y para perfusión EFG, LIDOCAINE HYDROCHLORIDE, Dexdor 100 micrograms/ml concentrate for solution for infusion, KETOLAR 50 mg/ml solución inyectable.

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  19. Sulforaphane

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    HIV Infections

    approved small molecule active

    1 trial

  20. Surabgene Lomparvovec (ABBV-RGX-314), Lucentis 10 mg/ml solution for injection in pre-filled syringe, Surabgene Lomparvovec (ABBV-RGX-314)

    AbbVie Deutschland GmbH & Co. KG

    Neovascular age-related macular degeneration

    approved small molecule active

    1 trial

  21. Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

    GT Biopharma

    Glioblastoma

    approved other active

    1 trial

  22. TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN

    The George Institute

    BK Polyomavirus DNAemia after kidney transplantation

    approved small molecule active

    1 trial

  23. TAGRISSO 80 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with EGFR mutant NSCLC according to TP53 mutational status

    approved small molecule active

    1 trial

  24. TESTOGEL 50 mg gel transdérmico en sobres, Decapeptyl diario 0,1 mg polvo y disolvente para solución inyectable, Bemfola 300 IU/0.50 mL solution for injection in pre-filled pen, Astarté 0,25 mg/0,5 ml solución inyectable en jeringa precargada EFG

    The George Institute

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources